Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Bogerts

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
MMW Fortschritte Der Medizin|March 11, 2005
[Delusional jealousy and obsessive love--causes and forms]Bernhard Bogerts
Schizophrenia Research|January 21, 2015
N-Methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disordersJohann Steiner, Bernhard Bogerts
Genome|December 5, 2013
Neuregulin-1 alpha, the underestimated molecule: emerging new roles in normal brain function and the pathophysiology of schizophrenia?Hans-Gert Bernstein, Bernhard Bogerts
The Journal of ECT|November 4, 2008
Electroconvulsive therapy in forensic psychiatry--ethical problems in daily practiceJoachim Witzel, Egbert Held, Bernhard Bogerts
CNS Spectrums|August 15, 2017
Brain alterations potentially associated with aggression and terrorismBernhard Bogerts, Maria Schöne, Stephanie Breitschuh
Expert Review of Neurotherapeutics|July 11, 2009
Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapyHans-Gert Bernstein, Johann Steiner, Bernhard Bogerts
Schizophrenia Research|July 12, 2005
The many faces of nitric oxide in schizophrenia. A reviewHans-Gert Bernstein, Bernhard Bogerts, Gerburg Keilhoff
Arteriosclerosis, Thrombosis, and Vascular Biology|November 21, 2008
Cathepsin K and metabolic abnormalities in schizophreniaHans-Gert Bernstein, Bernhard Bogerts, Uwe Lendeckel
CNS & Neurological Disorders Drug Targets|September 18, 2013
Risk factors for suicide--an alternative viewTim Johannes Krause, Bernhard Bogerts, Axel Genz
Medical Hypotheses|January 20, 2004
Electro-convulsive therapy, nitric oxide and HPA axis: a closer look at human hypothalamusHans Gert Bernstein, Arndt Heinemann, Bernhard Bogerts
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
MMW Fortschritte Der Medizin|March 11, 2005
[Delusional jealousy and obsessive love--causes and forms]Bernhard Bogerts
Schizophrenia Research|January 21, 2015
N-Methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disordersJohann Steiner, Bernhard Bogerts
Genome|December 5, 2013
Neuregulin-1 alpha, the underestimated molecule: emerging new roles in normal brain function and the pathophysiology of schizophrenia?Hans-Gert Bernstein, Bernhard Bogerts
The Journal of ECT|November 4, 2008
Electroconvulsive therapy in forensic psychiatry--ethical problems in daily practiceJoachim Witzel, Egbert Held, Bernhard Bogerts
CNS Spectrums|August 15, 2017
Brain alterations potentially associated with aggression and terrorismBernhard Bogerts, Maria Schöne, Stephanie Breitschuh
Expert Review of Neurotherapeutics|July 11, 2009
Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapyHans-Gert Bernstein, Johann Steiner, Bernhard Bogerts
Schizophrenia Research|July 12, 2005
The many faces of nitric oxide in schizophrenia. A reviewHans-Gert Bernstein, Bernhard Bogerts, Gerburg Keilhoff
Arteriosclerosis, Thrombosis, and Vascular Biology|November 21, 2008
Cathepsin K and metabolic abnormalities in schizophreniaHans-Gert Bernstein, Bernhard Bogerts, Uwe Lendeckel
CNS & Neurological Disorders Drug Targets|September 18, 2013
Risk factors for suicide--an alternative viewTim Johannes Krause, Bernhard Bogerts, Axel Genz
Medical Hypotheses|January 20, 2004
Electro-convulsive therapy, nitric oxide and HPA axis: a closer look at human hypothalamusHans Gert Bernstein, Arndt Heinemann, Bernhard Bogerts
Pageof 21